Moreover, IL-6 together with TNF-α is considered a mediator of systemic COPD effects (cachexia, skeletal muscle dysfunction, cardiovascular diseases, depression, hypodynamia, and osteoporosis), leading to an unfavorable outcome [32]. This evidence concerns the gene IL6 and depressive symptom measurement.